Tanglewood Legacy Advisors’s AbbVie ABBV Stock Holding History

Tanglewood Legacy Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$111K	Hold	443	–	–	0.04%	125
2026 Q1	$96.3K	Sell	443 -35	-7%	-$7.76K	0.03%	129
2025 Q4	$109K	Hold	478	–	–	0.04%	126
2025 Q3	$111K	Hold	478	–	–	0.04%	125
2025 Q2	$88.7K	Sell	478 -55	-10%	-$10.2K	0.04%	135
2025 Q1	$112K	Hold	533	–	–	0.05%	121
2024 Q4	$94.7K	Hold	533	–	–	0.04%	134
2024 Q3	$105K	Hold	533	–	–	0.05%	119
2024 Q2	$91.4K	Hold	533	–	–	0.04%	126
2024 Q1	$97.1K	Hold	533	–	–	0.05%	123
2023 Q4	$82.6K	Hold	533	–	–	0.05%	125
2023 Q3	$79.4K	Hold	533	–	–	0.05%	127
2023 Q2	$71.8K	Hold	533	–	–	0.04%	136
2023 Q1	$84.9K	Hold	533	–	–	0.05%	121
2022 Q4	$86.1K	Buy	+533	New	+$81.7K	0.06%	104

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tanglewood Legacy Advisors's ABBV Position: Q2 2026 in Review

Tanglewood Legacy Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 443 shares worth $111K. The position accounts for 0.04% of the portfolio, ranked #125.

Tanglewood Legacy Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $112K in Q1 2025. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Tanglewood Legacy Advisors held 443 shares of AbbVie worth $111K as of Q2 2026.
Tanglewood Legacy Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.04% of Tanglewood Legacy Advisors's portfolio in Q2 2026, its #125 holding.
Tanglewood Legacy Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
Tanglewood Legacy Advisors's AbbVie position peaked at $112K in Q1 2025.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tanglewood Legacy Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.